Ceresetto, J., and F. Bottaro. “Idarucizumab: Reversal Agent for dabigatrán”. Journal of Hematology, vol. 22, no. 3, Jan. 2019, pp. 315-21, https://revistahematologia.com.ar/index.php/Revista/article/view/46.